(Q34097583)

31 July 2017

1 reference

title

The role of active treatment in early prostate cancer (English)

1 reference

31 July 2017

1 reference

Denis LJ

1

1 reference

31 July 2017

1 December 2000

1 reference

Radiotherapy and Oncology

31 July 2017

1 reference

31 July 2017

57

1 reference

31 July 2017

3

1 reference

31 July 2017

251-258

1 reference

Deferred treatment of locally advanced nonmetastatic prostate cancer: a long-term followup

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

External beam radiation monotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Patient-reported complications after cryoablation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Control of prostate cancer with radiotherapy: long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Most prostate cancers missed by raising the upper limit of normal prostate-specific antigen for men in their sixties are clinically significant.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Long-term results of radiation therapy for prostate cancer recurrence following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Report of the consensus workshop on screening and global strategy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Incontinence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Patient-re ported complications and follow-up treatment after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Results of radical prostatectomy in men with clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Salvage brachytherapy for localized prostate cancer after radiotherapy failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Laparoscopic radical prostatectomy: initial experience and preliminary assessment after 65 operations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

The management of locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Correlation between preoperative predictors and pathologic features in radical prostatectomy specimens in PSA-based screening

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Update on the treatment of prostate cancer with external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Population-based study of long-term survival in patients with clinically localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy--a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Is the percentage of cancer in biopsy cores predictive of extracapsular disease in T1-T2 prostate carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

The results of prostate carcinoma screening in the U.S. as reflected in the surveillance, epidemiology, and end results program

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Should Gleason score 7 prostate cancer be considered a unique grade category?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Surgery or radiation: is there really a choice for early prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Prostate cancer: screening or watchful waiting?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Retropubic Implantation of Iodine 125 in the Treatment of Prostatic Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2800%2900284-X

7 January 2021

10.1016/S0167-8140(00)00284-X

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11104881